RRR INFORMATION

A risk Assessment Calculator for Diabetic Patients who Fast during Ramadan
This Ramadan Risk Rate stratification tool is based on a classification model that can be used quickly and accurately to grade diabetic patients into various categories using patient anthropometric, clinical and biochemical data. Each component is given points according to the degree of risk it poses during Ramadan fasting to the diabetic patient.
This tool will be useful for healthcare practitioners in evaluating the level of risk of their diabetic patients quickly and noninvasively and subsequently plan future strategy accordingly.
In this application is also incorporated further management strategies of individual patients. This is based on the risk score the patient achieves. Depending on the score patients are categorized into low, moderate or high-risk group. Thus the management is individualized according to the risk grade.
Based on the information obtained at the time of presentation , patients are Risk stratified according to evidence based risk criteria including gender , age, profession , type, duration and control of diabetes, complications both acute and chronic, co-morbid conditions and treatment they are receiving .Each risk criteria is given points depending on the level of the risk. Finally each patient is given a cumulative score based on the ten predetermined criteria and thus stratified as, Low Risk, Moderate Risk, High Risk and Very High Risk.

References
.Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A, the EPIDIAR Study Group: A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27: 2306–2311, 2004

.Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim 8 MA, et al. American Diabetes Association recommendations for management of diabetes during Ramadan. Diabetes Care 2005;28:2305-11.

.Clark M. Diabetes self management education: a review of published studies. Prim Care Diabetes 2008; 2: 113-20.

.International Diabetes Federation. Diabetes Education. IDF: Brussels; 2009.

.Al Sifri S, Basiounny A, Echtay A, et al. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: A randomised trial. Int J Clin Pract 2011;65:1132-40.

. Hassan A, Meo SA, Usmani AM, Shaikh TJ. Diabetes during Ramadan - PRE-approach model: presentation, risk stratification, education. Eur Rev Med Pharmacol Sci. 2014;18(12):1798-805

.Babineaux SM, Toaima D, Boye KS, et al. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 2015;32:819-28.

.Diabetes and Ramadan: Practical Guidelines International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance April 2016